Calyxo

Pleasanton, United States

Calyxo is a medical device company that improves kidney stone treatment through specialized urology technologies.

$28.3M raised

Apr 2026

Series F

Top Investors

Janus Henderson InvestorsAlly Bridge GroupAvidity PartnersQuesta Capital ManagementCRG

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Calyxo raised?

Calyxo has raised $28.3M in total funding. The most recent round was Series F. The last funding was announced in April 2026.

Who are Calyxo's investors?

Calyxo's investors include Janus Henderson Investors, Ally Bridge Group, Avidity Partners, Questa Capital Management, CRG.

Where is Calyxo headquartered?

Calyxo is headquartered in Pleasanton, United States.

What does Calyxo do?

Calyxo is a medical device company that improves kidney stone treatment through specialized urology technologies.

What stage is Calyxo at?

Calyxo is at the Series F stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 14, 2026.

MLA

"Calyxo — Funding & Investors." VCBacked, April 14, 2026, https://www.vcbacked.co/company/calyxo. Accessed June 17, 2026.

APA

VCBacked. (2026). Calyxo — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/calyxo

Wikipedia (cite web)

{{cite web |title=Calyxo — Funding & Investors |url=https://www.vcbacked.co/company/calyxo |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 14, 2026.